https://www.cochrane.org/fr/CD014544/CF_quels-sont-les-benefices-et-les-risques-des-nouveaux-traitements-par-facteurs-non-coagulants-pour-la 2024 United Kingdom review of literature french abstract risk factors blood coagulation factors hemophilia B bloodletting coagulants Treatment Benefit Feeding Breeding Risk Factor Coagulation Factor hemophilia b, nos persons risks and benefits risk factor F9 wt Allele Feeding Ability Prevention Study Hemophilia B What Month is it disease Raw coagulation factor, nos Hemorrhage Preventive Intervention risk assessment bleeding precautions hemorrhage People New Lesion Identification Newar Language preventive treatment, nos
--- https://anpgm.fr/media/documents/anpgm_135-deficits_constitutionnels_rares_en_facteurs_de_coagulation.pdf 2018 France guideline hemophilia b, nos coagulation factor, nos Hemophilia B blood coagulation disorder, nos genes coagulants hemophilia B von willebrand diseases von willebrand factor Rare disease Coagulation factors rare diseases Diseases coagulants